IE42951B1 - Injectable antibiotic compositions - Google Patents

Injectable antibiotic compositions

Info

Publication number
IE42951B1
IE42951B1 IE261/76A IE26176A IE42951B1 IE 42951 B1 IE42951 B1 IE 42951B1 IE 261/76 A IE261/76 A IE 261/76A IE 26176 A IE26176 A IE 26176A IE 42951 B1 IE42951 B1 IE 42951B1
Authority
IE
Ireland
Prior art keywords
composition according
composition
dispersing agent
amoxycillin
lecithin
Prior art date
Application number
IE261/76A
Other languages
English (en)
Other versions
IE42951L (en
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Publication of IE42951L publication Critical patent/IE42951L/xx
Publication of IE42951B1 publication Critical patent/IE42951B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IE261/76A 1975-03-07 1976-02-10 Injectable antibiotic compositions IE42951B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9515/75A GB1532993A (en) 1975-03-07 1975-03-07 Injectable antibiotic compositions

Publications (2)

Publication Number Publication Date
IE42951L IE42951L (en) 1976-09-07
IE42951B1 true IE42951B1 (en) 1980-11-19

Family

ID=9873459

Family Applications (1)

Application Number Title Priority Date Filing Date
IE261/76A IE42951B1 (en) 1975-03-07 1976-02-10 Injectable antibiotic compositions

Country Status (26)

Country Link
US (1) US4876086A (en:Method)
JP (1) JPS5914004B2 (en:Method)
AR (1) AR211700A1 (en:Method)
AT (1) AT344317B (en:Method)
AU (1) AU502790B2 (en:Method)
BE (1) BE839109A (en:Method)
CA (1) CA1045549A (en:Method)
DD (1) DD124866A5 (en:Method)
DE (1) DE2608079C2 (en:Method)
DK (1) DK153123C (en:Method)
FI (1) FI760503A7 (en:Method)
FR (1) FR2302736A1 (en:Method)
GB (1) GB1532993A (en:Method)
GR (1) GR59302B (en:Method)
HU (1) HU170250B (en:Method)
IE (1) IE42951B1 (en:Method)
IL (1) IL49009A (en:Method)
IT (1) IT1061681B (en:Method)
MX (1) MX5599E (en:Method)
NL (1) NL187835C (en:Method)
NO (1) NO760767L (en:Method)
NZ (1) NZ179948A (en:Method)
PT (1) PT64813B (en:Method)
SE (1) SE425762B (en:Method)
ZA (1) ZA76926B (en:Method)
ZM (1) ZM2076A1 (en:Method)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2374031A1 (fr) * 1976-12-17 1978-07-13 Scherico Ltd Nouvelles formulations d'antibiotiques b-lactame, leur procede de preparation, melange antibiotique injectable ainsi que son procede de preparation
EP0008905B1 (en) * 1978-09-06 1983-02-16 Beecham Group Plc Pharmaceutical compositions containing two beta-lactam derivatives
DE2965732D1 (en) * 1978-12-08 1983-07-28 Beecham Group Plc Pharmaceutical composition comprising a water soluble salt of amoxycillin and polyvinylpyrrolidone, and a vial containing a unit dose of said composition
EP0080862B1 (en) * 1981-12-02 1985-09-25 Beecham Group Plc Pharmaceutical formulation comprising beta-lactam antibiotics
FR2594334B1 (fr) * 1986-02-20 1990-01-12 Bristol Myers Co Composition pharmaceutique injectable a base d'amoxicilline
GB8629481D0 (en) * 1986-12-10 1987-01-21 Beecham Group Plc Veterinary treatment
US4898728A (en) * 1988-04-07 1990-02-06 Beecham Group P.L.C. Process for production of composition containing lecithin and polyvinylpyrrolidone
IT1230095B (it) * 1989-04-27 1991-10-05 Parenta Srl Procedimento per la preparazione di forme sterili di polveri iniettabili di antibiotici.
MX9201782A (es) * 1991-04-19 1992-10-01 Sandoz Ag Particulas de sustancias biologicamente activas, sustancialmente insolubles en agua, proceso para su produccion y composicion farmaceutica que las contiene.
US6447806B1 (en) 1999-02-25 2002-09-10 Novartis Ag Pharmaceutical compositions comprised of stabilized peptide particles
WO2000050036A1 (en) * 1999-02-26 2000-08-31 Biovail International Ltd. Storage stable amoxycillin and clavulanate suspension composition

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB660511A (en) * 1948-07-14 1951-11-07 Squibb & Sons Inc Penicillin compositions and methods of preparing them
GB705343A (en) * 1952-02-01 1954-03-10 Lilly Co Eli Improvements in or relating to aqueous suspensions of procaine penicillin
US2897120A (en) * 1954-05-04 1959-07-28 Upjohn Co Low viscosity cmc pharmaceutical vehicle
US2939818A (en) * 1957-04-09 1960-06-07 Pfizer & Co C Aqueous therapeutic compositions
US3062718A (en) * 1959-10-27 1962-11-06 Pfizer & Co C Stable aqueous streptomycinpenicillin composition
BE719923A (en:Method) * 1964-05-20 1969-02-24
NL143423B (nl) * 1968-01-18 1974-10-15 Bristol Myers Co Werkwijze voor het bereiden van een penicillinepreparaat, dat een bevochtigingsmiddel bevat.
GB1241844A (en) * 1968-08-23 1971-08-04 Beecham Group Ltd Penicillins
US3634586A (en) * 1968-12-04 1972-01-11 Bristol Myers Co Stable aqueous suspensions of ampicillin
US3703511A (en) * 1969-06-06 1972-11-21 Squibb & Sons Inc Alpha-aminobenzyl penicillins
US3737545A (en) * 1972-02-22 1973-06-05 Squibb & Sons Inc Alpha-aminobenzyl penicillins
GB1403584A (en) * 1972-05-19 1975-08-28 Beecham Group Ltd Control medicaments
US3969524A (en) * 1974-08-13 1976-07-13 Hoffmann-La Roche Inc. Stable amoxicillin dosage form
DE2965732D1 (en) * 1978-12-08 1983-07-28 Beecham Group Plc Pharmaceutical composition comprising a water soluble salt of amoxycillin and polyvinylpyrrolidone, and a vial containing a unit dose of said composition

Also Published As

Publication number Publication date
AR211700A1 (es) 1978-02-28
FI760503A7 (en:Method) 1976-09-08
IE42951L (en) 1976-09-07
DK98076A (da) 1976-09-08
GR59302B (en) 1977-12-12
DD124866A5 (en:Method) 1977-03-16
PT64813A (en) 1976-03-01
MX5599E (es) 1983-11-07
IT1061681B (it) 1983-04-30
IL49009A (en) 1979-09-30
FR2302736B1 (en:Method) 1979-10-05
FR2302736A1 (fr) 1976-10-01
AU502790B2 (en) 1979-08-09
NZ179948A (en) 1978-09-25
NL187835B (nl) 1991-09-02
DK153123C (da) 1988-10-31
PT64813B (en) 1977-07-11
US4876086A (en) 1989-10-24
SE7601535L (sv) 1976-09-08
ZA76926B (en) 1977-01-26
NL187835C (nl) 1992-02-03
DE2608079A1 (de) 1976-09-16
AT344317B (de) 1978-07-10
BE839109A (fr) 1976-09-02
JPS51112510A (en) 1976-10-05
NL7602180A (nl) 1976-09-09
IL49009A0 (en) 1976-04-30
DE2608079C2 (de) 1985-11-14
AU1178976A (en) 1977-09-15
DK153123B (da) 1988-06-20
SE425762B (sv) 1982-11-08
HU170250B (en:Method) 1977-05-28
GB1532993A (en) 1978-11-22
NO760767L (en:Method) 1976-09-08
ATA156576A (de) 1977-11-15
JPS5914004B2 (ja) 1984-04-02
ZM2076A1 (en) 1977-08-22
CA1045549A (en) 1979-01-02

Similar Documents

Publication Publication Date Title
DE69617036T2 (de) Verwendung einer amoxicillin und clavulanat enthaltenden paediatrischen pharmazeutischen formulierung
DE60026538T2 (de) Pharmazeutische zubereitungen die clavulansäure oder derivate enthalten zur behandlung von neurologischen störungen
EP2062581B1 (en) The antibiotics composition comprising beta-lactam antibiotics and ionic chelating agents
IE42951B1 (en) Injectable antibiotic compositions
CH671157A5 (de) Stabiles pharmazeutisches praeparat, enthaltend granulocytkolonie stimulierender faktor, und verfahren zur herstellung desselben.
JPS6191131A (ja) 医薬品の吸着防止方法および組成物
UA46763C2 (uk) Спосіб лікування бактеріальних інфекцій у педіатричних пацієнтів та фармацевтичні композиції на основі тригідрату амоксициліну та клавуланату калію (варіанти)
NZ232979A (en) Edible non-aqueous pharmaceutical formulation and container incorporating it
CN1681497A (zh) 口服给药用的可分散片剂
US4477452A (en) Composition of matter comprising a lyophilized preparation of a penicillin derivative
US3780170A (en) Tasteless methenamine mandelate
US3879511A (en) Tasteless methenamine mandelate in a stabilized vegetable oil suspension
US4423033A (en) Pharmaceutical compositions
US4534977A (en) Composition of matter comprising a low bulk density lyophilized preparation of Sodium Piperacillin
US3634586A (en) Stable aqueous suspensions of ampicillin
US2518510A (en) Stable injectable oil-pectin therapeutic compositions
AU661944B2 (en) An aqueous suspension
US2966442A (en) Antibiotic compositions
CN101003539A (zh) 西林类化合物的氨丁三醇盐及其制备方法
US2733184A (en) Inject able penicillin repository prep ar a-
EP0008905B1 (en) Pharmaceutical compositions containing two beta-lactam derivatives
US4029782A (en) Cefazolin suspension for parenteral administration
CA1209477A (en) Composition of matter comprising a lyophilized preparation of a penicillin derivative
AU611806B2 (en) Veterinary composition containing ampicillin and cloxacillin for treating eye infection
EP1326608B1 (en) Stable compositions of oxapenem-3-carboxylic acids by co-lyophilisation with pharmaceutical carriers